While dendritic cell vaccines are primarily being explored in the context of cancer immunotherapy, they hold potential for treating other diseases as well. Currently, these vaccines are being tested in clinical trials for various types of cancers, including melanoma, prostate cancer, and glioblastoma. Future research may extend their application to infectious diseases and autoimmune disorders.